- Home
- MMA vs SNTI Comparison
MMA vs SNTI Comparison
Compare MMA & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- SNTI
- Stock Information
- Founded
- MMA 2013
- SNTI 2016
- Country
- MMA Australia
- SNTI United States
- Employees
- MMA N/A
- SNTI N/A
- Industry
- MMA
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- SNTI Health Care
- Exchange
- MMA Nasdaq
- SNTI Nasdaq
- Market Cap
- MMA 18.8M
- SNTI 18.2M
- IPO Year
- MMA 2024
- SNTI N/A
- Fundamental
- Price
- MMA $1.27
- SNTI $3.82
- Analyst Decision
- MMA
- SNTI Strong Buy
- Analyst Count
- MMA 0
- SNTI 1
- Target Price
- MMA N/A
- SNTI $12.00
- AVG Volume (30 Days)
- MMA 17.7K
- SNTI 7.2M
- Earning Date
- MMA 12-31-2024
- SNTI 11-14-2024
- Dividend Yield
- MMA N/A
- SNTI N/A
- EPS Growth
- MMA N/A
- SNTI N/A
- EPS
- MMA N/A
- SNTI N/A
- Revenue
- MMA $375,175.00
- SNTI N/A
- Revenue This Year
- MMA N/A
- SNTI $254.47
- Revenue Next Year
- MMA N/A
- SNTI $169.66
- P/E Ratio
- MMA N/A
- SNTI N/A
- Revenue Growth
- MMA 45.19
- SNTI N/A
- 52 Week Low
- MMA $1.15
- SNTI $1.52
- 52 Week High
- MMA $5.25
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- MMA N/A
- SNTI 46.43
- Support Level
- MMA N/A
- SNTI $3.60
- Resistance Level
- MMA N/A
- SNTI $4.29
- Average True Range (ATR)
- MMA 0.00
- SNTI 0.80
- MACD
- MMA 0.00
- SNTI -0.32
- Stochastic Oscillator
- MMA 0.00
- SNTI 6.22
About MMA Alta Global Group Limited
Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.